Assertion: placebo | /r/HasProperty | 2.1%
Facets:
Source sentences:
text: Endocrine & metabolic: Hyperglycemia (1.8% [placebo 2.1%]) (Beigel 2020), increased serum glucose (2.2% [placebo 1.1%]) (Beigel 2020)
text: In the study of pediatric patients (10 to 17 years of age) with bipolar mania, four common adverse reactions had a possible dose response relationship at 4 weeks; extrapyramidal disorder (incidences were placebo, 3.1%; 10 mg, 12.2%; 30 mg, 27.3%); somnolence (incidences were placebo, 3.1%; 10 mg, 19.4%; 30 mg, 26.3%); akathisia (incidences were placebo, 2.1%; 10 mg, 8.2%; 30 mg, 11.1%); and salivary hypersecretion (incidences were placebo, 0%; 10 mg, 3.1%; 30 mg, 8.1%).